Your session is about to expire
← Back to Search
Metreleptin for Partial Lipodystrophy (METRE-PL Trial)
METRE-PL Trial Summary
This trial is testing whether a daily injection of metreleptin is safe and effective for people with Partial Lipodystrophy.
METRE-PL Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMETRE-PL Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.METRE-PL Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been treated with metreleptin before.I have been diagnosed with Familial Partial Lipodystrophy.
- Group 1: metreleptin
- Group 2: placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has metreleptin received approval from the Federal Drug Administration?
"The safety of metreleptin is estimated to be a 3. This assessment comes from Phase 3 trial data, which provides some evidence of the medication's efficacy as well as multiple rounds of supporting data for safety."
Are people with the specific condition being studied presently able to enroll in this trial?
"Yes, this trial is still open and looking for participants. The listing on clinicaltrials.gov says that the first posting was on December 17th, 2021 and the last update was on November 2nd, 2022."
Could you tell me how many people are testing this new medication?
"Yes, according to the latest update on clinicaltrials.gov, this study is still enrolling patients. The listing was first posted on December 17th, 2021 and updated as recently as November 2nd, 2022. They are looking for a total of 65 participants across 1 site."
Does metreleptin have a long research history?
"Currently, there are 5 ongoing clinical trials studying the effects of metreleptin. Out of these 5, 2 are in Phase 3. The research being conducted is primarily based in Columbus, Ohio; however, there are 14 trial locations across the United States."
Share this study with friends
Copy Link
Messenger